tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Terence Flynn, 112 are a HOLD (36.36%), 36 are a SELL (11.69%), 160 are a BUY (51.95%).
Analyst Terence Flynn, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 67.35% that have a potential upside of 20.7% achieved within 237 days.
Terence Flynn’s has documented 641 price targets and ratings displayed on 40 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LLY, Eli Lilly and Company at 02-Oct-2025.
Analyst best performing recommendations are on TBIO (TELESIS BIO).
The best stock recommendation documented was for ARVN (ARVINAS) at 11/13/2023. The price target of $20 was fulfilled within 2 days with a profit of $3.41 (20.55%) receiving and performance score of 102.77.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$35
$3.94 (12.69%)
$34
1 months 1 days ago
(08-Sep-2025)
8/9 (88.89%)
$7.15 (25.67%)
112
Hold
$46
$14.94 (48.10%)
$46
1 months 1 days ago
(08-Sep-2025)
19/25 (76%)
$18.15 (65.17%)
295
Buy
$45
$13.94 (44.88%)
$45
2 months 11 days ago
(28-Jul-2025)
0/3 (0%)
$18 (66.67%)
Buy
$42
$10.94 (35.22%)
$38
3 months 23 days ago
(16-Jun-2025)
2/4 (50%)
$12.23 (41.08%)
86
Buy
$41
$9.94 (32.00%)
$38
5 months 8 days ago
(01-May-2025)
0/2 (0%)
$9.22 (29.01%)
Which stock is Terence Flynn is most bullish on?
Which stock is Terence Flynn is most reserved on?
What Year was the first public recommendation made by Terence Flynn?
